Acute urate nephropathy

This MedLibrary.org supplementary page on Acute urate nephropathy is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Acute uric acid nephropathy (AUAN, also acute urate nephropathy) is a rapidly worsening (decreasing) kidney function (renal insufficiency) that is caused by high levels of uric acid in the urine (hyperuricosuria).

Contents

Causes

Acute uric acid nephropathy is usually seen as part of the tumor lysis syndrome in patients undergoing chemotherapy or radiation therapy for the treatment of malignancies with rapid cell turnover, such as leukemia and lymphoma. It may also occur in these patients before treatment is begun, due to spontaneous tumor cell lysis (high incidence in Burkitt's lymphoma).

Acute uric acid nephropathy can also be caused by an acute attack of gout.

Pathophysiology

Acute uric acid nephropathy is caused by deposition of uric acid crystals within the kidney interstitium and tubules, leading to partial or complete obstruction of collecting ducts, renal pelvis, or ureter. This obstruction is usually bilateral, and patients follow the clinical course of acute renal failure.

Diagnosis

The picture of acute renal failure is observed: decreased urine production and rapidly rising serum creatinine levels. Acute uric acid nephropathy is differentiated from other forms of acute renal failure by the finding of a urine uric acid/creatinine ratio > 1 in a random urine sample.

Prevention

Patients at risk for acute uric acid nephropathy should be treated with allopurinol prior to treatment with cytotoxic drugs.

Treatment

Treatment is focused on preventing deposition of uric acid within the urinary system by increasing urine volume with potent diuretics such as furosemide. The urine must also be alkalinized to pH > 7 using sodium bicarbonate and/or acetazolamide to increase uric acid solubility.

Dialysis (preferably hemodialysis) is started if the above measures fail.

References

  • Conger JD (1990). "Acute uric acid nephropathy". Med Clin North Am 74 (4): 859–71.  PMID 2195258
  • Robinson RR, Yarger WE (1977). "Acute uric acid nephropathy". Arch Intern Med 137 (7): 839–40. doi:10.1001/archinte.137.7.839.  PMID 879920
  • Yu ASL, Brenner BM (2005). "Chapter 266: Tubulointerstitial diseases of the kidney". in Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL. Harrison's Principles of Internal Medicine (16th edition ed.). New York: McGraw-Hill Professional.  ISBN 978-0-07-140235-4

Wikipedia content modification information:

  • This page was last modified on 24 October 2008, at 17:26.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Acute urate nephropathy".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.